SPOK
Spok Holdings, IncPrice & Indicators
Blended from price, positioning & fundamentals · daily-close · not investment advice.
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $5,259K | three months ended March 31, 2026 | — |
| Adjusted operating expenses non-GAAP | $29,468K | three months ended March 31, 2026 | — |
| Six-figure customer contracts (software operations bookings) | 17 | three months ended March 31, 2026 | — |
| Software backlog | $58.2M | as of December 31, 2025 | — |
| Wireless quarterly net churn | 1.3% | Q4 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SPOK
this stock
Spok Holdings, Inc
|
$219.10M | -18.3% | +1.5% | 17.8 | 2.2% |
|
VEEV
Veeva Systems Inc
|
$31.19B | -14.0% | +28.1% | 34.0 | 4.6% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$15.67B | -9.4% | — | — | 0.0% |
|
BTSG
BrightSpring Health Services, Inc.
|
$13.39B | +84.3% | -0.4% | 49.3 | 4.8% |
|
TEM
Tempus AI, Inc.
|
$11.14B | +2.1% | +65.8% | — | 21.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SPOK | +0.5% | -0.9% | -18.2% | +2.4% | -18.3% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -1.0% | +0.3% | -26.3% | +2.7% | -27.5% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.